Sygnature Discovery Nottingham is the UK's leading drug discovery research center, offering significant knowledge and expertise across a wide range of therapeutic areas. With a team of scientists who hold advanced degrees and bring pharmaceutical industry experience, we provide integrated drug discovery and non-clinical solutions to advance our clients' projects. Our success stems from a unique synergy of chemistry, bioscience, drug metabolism and pharmacokinetics, computational design, and in vivo pharmacology.

Our approach involves co-locating multiple disciplines on the same research site, fostering collaboration and innovation. From target discovery to preclinical research, Sygnature has the right approach, team, and tools to enable success. We have a track record of delivering over 40 pre-clinical compounds and 22 clinical compounds, with our scientists named on over 160 customer patent applications.

Our vision is to revolutionize drug discovery, and our mission is to discover, invent, and implement new processes that drive drug discovery success. Partnering with Sygnature Discovery means giving your project the best chance of success. Contact us today to learn more